RET-IN-13

RET-IN-13 is a potent quinoline-derived RET kinase inhibitor, with IC50 values of 0.5 nM for wild-type RET and 0.9 nM for the V804M mutant. It is a valuable research tool for investigating RET-driven pathologies, including cancers and gastrointestinal disorders, in both cellular and animal models.